• company
  • SLP concept
    • SLP therapy is synergistic
    • publications
  • technology
    • SLP technology
    • AMPLIVANT technology
  • pipeline
    • ISA101b (HPV16)
    • ISA103 (PRAME)
    • ISA104 (HBV)
    • ISA106 (SARS-CoV2)
    • MyISA®
  • clinical studies
  • partners
  • news archive
  • careers
  • contact
  1. Home
  2. Uncategorized
  3. Protected: ISA pen

Protected: ISA pen

21 Feb 2022

This content is password protected. To view it please enter your password below:

Previous ISA to present key learnings for cancer vaccine development at the ESMO Immuno-Oncology Congress
Next ISA Completes Enrolment in Randomized Double Blind Phase 2 Clinical Trial of ISA101b in HPV16 induced Oropharyngeal Cancer

This post is password protected. Enter the password to view any comments.

  • disclaimer
  • privacy statement

© 2019 Scicomvisuals, all rights reserved.